Lucosky Brookman Successfully Represents BiondVax Pharmaceuticals Ltd. in Closing of $9.8 million Follow-on Underwritten Offering of ADSs
Lucosky Brookman LLP congratulates its client, BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) on its successful closing of an underwritten…
Read More